» Articles » PMID: 21844368

Computationally Designed Adeno-associated Virus (AAV) Rep 78 is Efficiently Maintained Within an Adenovirus Vector

Overview
Specialty Science
Date 2011 Aug 17
PMID 21844368
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Adeno-associated virus (AAV) is a single-stranded parvovirus retaining the unique capacity for site-specific integration into a transcriptionally silent region of the human genome, a characteristic requiring the functional properties of the Rep 78/68 polypeptide in conjunction with AAV terminal repeat integrating elements. Previous strategies designed to assemble these genetic elements into adenoviral (Ad) backbones have been limited by the general intolerability of AAV Rep sequences, prompting us to computationally reengineer the Rep gene by using synonymous codon pair recoding. Rep mutants generated by using de novo genome synthesis maintained the polypeptide sequence and endonuclease properties of Rep 78, while dramatically enhancing Ad replication and viral titer yields, characteristics indistinguishable from adenovirus lacking coexpressed Rep. Parallel approaches using domain swaps encompassing WT and recoded genomic segments, coupled with iterative computational algorithms, collectively established that 3' cis-acting Rep genetic elements (and not the Rep 78 polypeptide) retain dominant-acting sequences inhibiting Ad replication. These data provide insights into the molecular relationships of AAV Rep and Ad replication, while expanding the applicability of synonymous codon pair reengineering as a strategy to effect phenotypic endpoints.

Citing Articles

Interferon-γ inducible factor 16 (IFI16) restricts adeno-associated virus type 2 (AAV2) transduction in an immune-modulatory independent way.

Sutter S, Tobler K, Seyffert M, Lkharrazi A, Zollig J, Schraner E J Virol. 2024; 98(7):e0011024.

PMID: 38837381 PMC: 11338077. DOI: 10.1128/jvi.00110-24.


AAV- based vector improvements unrelated to capsid protein modification.

Shitik E, Shalik I, Yudkin D Front Med (Lausanne). 2023; 10:1106085.

PMID: 36817775 PMC: 9935841. DOI: 10.3389/fmed.2023.1106085.


High-Level rAAV Vector Production by rAdV-Mediated Amplification of Small Amounts of Input Vector.

Weger S Viruses. 2023; 15(1).

PMID: 36680104 PMC: 9867474. DOI: 10.3390/v15010064.


Self-attenuating adenovirus enables production of recombinant adeno-associated virus for high manufacturing yield without contamination.

Su W, Patricio M, Duffy M, Krakowiak J, Seymour L, Cawood R Nat Commun. 2022; 13(1):1182.

PMID: 35256603 PMC: 8901928. DOI: 10.1038/s41467-022-28738-2.


Compositional biases in RNA viruses: Causes, consequences and applications.

Gaunt E, Digard P Wiley Interdiscip Rev RNA. 2021; 13(2):e1679.

PMID: 34155814 PMC: 8420353. DOI: 10.1002/wrna.1679.


References
1.
Fisher K, Kelley W, Burda J, Wilson J . A novel adenovirus-adeno-associated virus hybrid vector that displays efficient rescue and delivery of the AAV genome. Hum Gene Ther. 1996; 7(17):2079-87. DOI: 10.1089/hum.1996.7.17-2079. View

2.
Wang H, Lieber A . A helper-dependent capsid-modified adenovirus vector expressing adeno-associated virus rep78 mediates site-specific integration of a 27-kilobase transgene cassette. J Virol. 2006; 80(23):11699-709. PMC: 1642588. DOI: 10.1128/JVI.00779-06. View

3.
Daya S, Cortez N, Berns K . Adeno-associated virus site-specific integration is mediated by proteins of the nonhomologous end-joining pathway. J Virol. 2009; 83(22):11655-64. PMC: 2772704. DOI: 10.1128/JVI.01040-09. View

4.
Berns K, Giraud C . Biology of adeno-associated virus. Curr Top Microbiol Immunol. 1996; 218:1-23. DOI: 10.1007/978-3-642-80207-2_1. View

5.
Cavazzana-Calvo M, Payen E, Negre O, Wang G, Hehir K, Fusil F . Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia. Nature. 2010; 467(7313):318-22. PMC: 3355472. DOI: 10.1038/nature09328. View